Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is the assessment of the efficacy of Ery-Dex (dexamethasone
intra-erythrocyte) versus placebo in maintaining patients with steroid-dependent Crohn's
disease in clinical remission throughout 12 months without oral steroids.